메뉴 건너뛰기




Volumn 5, Issue 3, 2003, Pages 171-176

Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: A new avenue to be explored

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANTHRACYCLINE; CARCINOEMBRYONIC ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; CYTOKERATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MUCIN 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

EID: 0042736476     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-003-0106-7     Document Type: Editorial
Times cited : (8)

References (77)
  • 1
    • 0035253701 scopus 로고    scopus 로고
    • Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center Experience
    • Brito RA, Valero V, Buzdar AU, et al.: Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: the University of Texas M.D. Anderson Cancer Center Experience. J Clin Oncol 2001, 19:628-633.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 628-633
    • Brito, R.A.1    Valero, V.2    Buzdar, A.U.3
  • 2
    • 0026741580 scopus 로고
    • Treatment of locally advanced breast cancer
    • Booser DJ, Hortobagyi GN: Treatment of locally advanced breast cancer. Semin Oncol 1992, 19:278-285.
    • (1992) Semin. Oncol. , vol.19 , pp. 278-285
    • Booser, D.J.1    Hortobagyi, G.N.2
  • 3
    • 0034034257 scopus 로고    scopus 로고
    • Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: Comparison of quantitative polymerase chain reaction and immunocytochemical techniques
    • Smith BM, Slade MJ, English J, et al.: Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. J Clin Oncol 2000, 18:1432-1439.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 1432-1439
    • Smith, B.M.1    Slade, M.J.2    English, J.3
  • 4
    • 0033996457 scopus 로고    scopus 로고
    • Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer
    • Braun S, Pantel K, Muller P, et al.: Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000, 342:525-533.
    • (2000) N. Engl. J. Med. , vol.342 , pp. 525-533
    • Braun, S.1    Pantel, K.2    Muller, P.3
  • 5
    • 0032781104 scopus 로고    scopus 로고
    • Doxorubicin gradients in human breast cancer
    • Lankelma J, Dekker H, Luque FR, et al.: Doxorubicin gradients in human breast cancer. Clin Cancer Res 1999, 5:1703-1707.
    • (1999) Clin. Cancer Res. , vol.5 , pp. 1703-1707
    • Lankelma, J.1    Dekker, H.2    Luque, F.R.3
  • 6
    • 0032713821 scopus 로고    scopus 로고
    • Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin
    • Abolhoda A, Wilson AE, Ross H, et al.: Rapid activation of MDR1 gene expression in human metastatic sarcoma after in vivo exposure to doxorubicin. Clin Cancer Res 1999, 5:3352-3356.
    • (1999) Clin. Cancer Res. , vol.5 , pp. 3352-3356
    • Abolhoda, A.1    Wilson, A.E.2    Ross, H.3
  • 7
    • 0033986270 scopus 로고    scopus 로고
    • Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
    • Braun S, Kentenich C, Janni W, et al.: Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol 2000, 18:80-86.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 80-86
    • Braun, S.1    Kentenich, C.2    Janni, W.3
  • 8
    • 0034901095 scopus 로고    scopus 로고
    • Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy
    • Kasimir-Bauer S, Mayer S, Bojko P, et al.: Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy. Clin Cancer Res 2001, 7:1582-1589.
    • (2001) Clin. Cancer Res. , vol.7 , pp. 1582-1589
    • Kasimir-Bauer, S.1    Mayer, S.2    Bojko, P.3
  • 10
    • 0031926839 scopus 로고    scopus 로고
    • Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
    • Fisher B, Bryant J, Wolmark N, et al.: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16:2672-2685.
    • (1998) J. Clin. Oncol. , vol.16 , pp. 2672-2685
    • Fisher, B.1    Bryant, J.2    Wolmark, N.3
  • 11
    • 0028941377 scopus 로고
    • Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
    • Powles TJ, Hickish TF, Makris A, et al.: Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995, 13:547-552.
    • (1995) J. Clin. Oncol. , vol.13 , pp. 547-552
    • Powles, T.J.1    Hickish, T.F.2    Makris, A.3
  • 12
    • 0035890633 scopus 로고    scopus 로고
    • Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
    • van der Hage JA, van de Velde CJ, Julien JP, et al.: Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001, 19:4224-4237.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 4224-4237
    • van der Hage, J.A.1    van de Velde, C.J.2    Julien, J.P.3
  • 13
    • 0024600538 scopus 로고
    • Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy: An EORTC Breast Cancer Cooperative Group Trial (10792)
    • Rubens RD, Bartelink H, Engelsman E, et al.: Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy: an EORTC Breast Cancer Cooperative Group Trial (10792). Eur J Cancer Clin Oncol 1989, 25:667-678.
    • (1989) Eur. J. Cancer Clin. Oncol. , vol.25 , pp. 667-678
    • Rubens, R.D.1    Bartelink, H.2    Engelsman, E.3
  • 14
    • 0025980221 scopus 로고
    • Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study)
    • Gazet JC, Ford HT, Coombes RC: Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study). Br J Cancer 1991, 63:279-282.
    • (1991) Br. J. Cancer , vol.63 , pp. 279-282
    • Gazet, J.C.1    Ford, H.T.2    Coombes, R.C.3
  • 15
    • 0027155354 scopus 로고
    • Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis
    • Attia-Sobol J, Ferriere JP, Cure H, et al.: Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysis. Eur J Cancer 1993, 29A:1081-1088.
    • (1993) Eur. J. Cancer , vol.29 A , pp. 1081-1088
    • Attia-Sobol, J.1    Ferriere, J.P.2    Cure, H.3
  • 16
    • 0027409344 scopus 로고
    • The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients
    • Chevallier B, Bastit P, Graic Y, et al.: The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients. Br J Cancer 1993, 67:594-601.
    • (1993) Br. J. Cancer , vol.67 , pp. 594-601
    • Chevallier, B.1    Bastit, P.2    Graic, Y.3
  • 17
    • 0032168519 scopus 로고    scopus 로고
    • Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: Prognostic and therapeutic implications
    • Karlsson YA, Malmstrom PO, Hatschek T, et al.: Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide: prognostic and therapeutic implications. Cancer 1998, 83:936-947.
    • (1998) Cancer , vol.83 , pp. 936-947
    • Karlsson, Y.A.1    Malmstrom, P.O.2    Hatschek, T.3
  • 18
    • 0022860622 scopus 로고
    • Primary chemotherapy in the treatment of inflammatory breast carcinoma: A study of 230 cases from the Institut Gustave-Roussy
    • Rouesse J, Friedman S, Sarrazin D, et al.: Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol 1986, 4:1765-1771.
    • (1986) J. Clin. Oncol. , vol.4 , pp. 1765-1771
    • Rouesse, J.1    Friedman, S.2    Sarrazin, D.3
  • 19
    • 0032946705 scopus 로고    scopus 로고
    • Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer
    • Honkoop AH, Luykx-de Bakker SA, Hoekman K, et al.: Prolonged neoadjuvant chemotherapy with GM-CSF in locally advanced breast cancer. Oncologist 1999, 4:106-111.
    • (1999) Oncologist , vol.4 , pp. 106-111
    • Honkoop, A.H.1    Luykx-de Bakker, S.A.2    Hoekman, K.3
  • 20
    • 0036643778 scopus 로고    scopus 로고
    • Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF
    • LeBedis C, Chen K, Fallavollita L, et al.: Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF. Int J Cancer 2002, 100:2-8.
    • (2002) Int. J. Cancer , vol.100 , pp. 2-8
    • LeBedis, C.1    Chen, K.2    Fallavollita, L.3
  • 21
    • 0028144438 scopus 로고
    • Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer
    • Disis ML, Calenoff E, McLaughlin G, et al.: Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res 1994, 54:16-20.
    • (1994) Cancer Res. , vol.54 , pp. 16-20
    • Disis, M.L.1    Calenoff, E.2    McLaughlin, G.3
  • 22
    • 0030033054 scopus 로고    scopus 로고
    • Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer
    • Schlom J, Kantor J, Abrams S, et al.: Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer. Breast Cancer Res Treat 1996, 38:27-39.
    • (1996) Breast Cancer Res. Treat. , vol.38 , pp. 27-39
    • Schlom, J.1    Kantor, J.2    Abrams, S.3
  • 23
    • 0025109257 scopus 로고
    • Immunohistological distribution of 5T4 antigen in normal and malignant tissues
    • Southall PJ, Boxer GM, Bagshawe KD, et al.: Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 1990, 61:89-95.
    • (1990) Br. J. Cancer , vol.61 , pp. 89-95
    • Southall, P.J.1    Boxer, G.M.2    Bagshawe, K.D.3
  • 24
    • 17344392248 scopus 로고    scopus 로고
    • Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin
    • von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, et al.: Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 2000, 18:574-583.
    • (2000) J. Clin. Oncol. , vol.18 , pp. 574-583
    • von Mensdorff-Pouilly, S.1    Verstraeten, A.A.2    Kenemans, P.3
  • 25
    • 0030934973 scopus 로고    scopus 로고
    • Decreased antigen presentation by dendritic cells in patients with breast cancer
    • Gabrilovich DI, Corak J, Ciernik IF, et al.: Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997, 3:483-490.
    • (1997) Clin. Cancer Res. , vol.3 , pp. 483-490
    • Gabrilovich, D.I.1    Corak, J.2    Ciernik, I.F.3
  • 26
    • 0032546352 scopus 로고    scopus 로고
    • Dendritic cells and the control of immunity
    • Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
    • (1998) Nature , vol.392 , pp. 245-252
    • Banchereau, J.1    Steinman, R.M.2
  • 28
    • 0030896205 scopus 로고    scopus 로고
    • Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines
    • Mayordomo JI, Zorina T, Storkus WJ, et al.: Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells 1997, 15:94-103.
    • (1997) Stem Cells , vol.15 , pp. 94-103
    • Mayordomo, J.I.1    Zorina, T.2    Storkus, W.J.3
  • 29
    • 0031896891 scopus 로고    scopus 로고
    • Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma
    • Coppola D, Fu L, Nicosia SV, et al.: Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma. Hum Pathol 1998, 29:455-462.
    • (1998) Hum. Pathol. , vol.29 , pp. 455-462
    • Coppola, D.1    Fu, L.2    Nicosia, S.V.3
  • 30
    • 0025816551 scopus 로고
    • Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance
    • Gallo O, Bianchi S, Giannini A, et al.: Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance. Laryngoscope 1991, 101:487-493.
    • (1991) Laryngoscope , vol.101 , pp. 487-493
    • Gallo, O.1    Bianchi, S.2    Giannini, A.3
  • 31
    • 0031827465 scopus 로고    scopus 로고
    • Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma
    • Ikeguchi M, Ikeda M, Tatebe S, et al.: Clinical significance of dendritic cell infiltration in esophageal squamous cell carcinoma. Oncol Rep 1998, 5:1185-1189.
    • (1998) Oncol. Rep. , vol.5 , pp. 1185-1189
    • Ikeguchi, M.1    Ikeda, M.2    Tatebe, S.3
  • 32
    • 0030711097 scopus 로고    scopus 로고
    • Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer
    • Ishigami S, Aikou T, Natsugoe S, et al.: Prognostic value of HLA-DR expression and dendritic cell infiltration in gastric cancer. Oncology 1998, 55:65-69.
    • (1998) Oncology , vol.55 , pp. 65-69
    • Ishigami, S.1    Aikou, T.2    Natsugoe, S.3
  • 33
    • 0031738664 scopus 로고    scopus 로고
    • Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue
    • Saito H, Tsujitani S, Ikeguchi M, et al.: Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. Br J Cancer 1998, 78:1573-1577.
    • (1998) Br. J. Cancer , vol.78 , pp. 1573-1577
    • Saito, H.1    Tsujitani, S.2    Ikeguchi, M.3
  • 34
    • 0037448353 scopus 로고    scopus 로고
    • Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
    • Zhang L, Conejo-Garcia JR, Katsaros D, et al.: Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003, 348:203-213.
    • (2003) N. Engl. J. Med. , vol.348 , pp. 203-213
    • Zhang, L.1    Conejo-Garcia, J.R.2    Katsaros, D.3
  • 35
    • 0033571785 scopus 로고    scopus 로고
    • In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
    • Bell D, Chomarat P, Broyles D, et al.: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999, 190:1417-1426.
    • (1999) J. Exp. Med. , vol.190 , pp. 1417-1426
    • Bell, D.1    Chomarat, P.2    Broyles, D.3
  • 36
    • 0033514923 scopus 로고    scopus 로고
    • Immune surveillance against a solid tumor fails because of immunological ignorance
    • Ochsenbein AF, Klenerman P, Karrer U, et al.: Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 1999, 96:2233-2238.
    • (1999) Proc. Natl. Acad. Sci. U. S. A. , vol.96 , pp. 2233-2238
    • Ochsenbein, A.F.1    Klenerman, P.2    Karrer, U.3
  • 37
    • 0031049941 scopus 로고    scopus 로고
    • Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor
    • Buelens C, Verhasselt V, De Groote D, et al.: Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol 1997, 27:756-762.
    • (1997) Eur. J. Immunol. , vol.27 , pp. 756-762
    • Buelens, C.1    Verhasselt, V.2    De Groote, D.3
  • 38
    • 0032400862 scopus 로고    scopus 로고
    • Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo
    • Gabrilovich D, Ishida T, Oyama T, et al.: Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998, 92:4150-4166.
    • (1998) Blood , vol.92 , pp. 4150-4166
    • Gabrilovich, D.1    Ishida, T.2    Oyama, T.3
  • 39
    • 0029842830 scopus 로고    scopus 로고
    • Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
    • Gabrilovich DI, Chen HL, Girgis KR, et al.: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat Med 1996, 2:1096-1103.
    • (1996) Nat. Med. , vol.2 , pp. 1096-1103
    • Gabrilovich, D.I.1    Chen, H.L.2    Girgis, K.R.3
  • 40
    • 0031013905 scopus 로고    scopus 로고
    • Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: Definition of a maturative step
    • Morel AS, Quaratino S, Douek DC, Londei M: Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol 1997, 27:26-34.
    • (1997) Eur. J. Immunol. , vol.27 , pp. 26-34
    • Morel, A.S.1    Quaratino, S.2    Douek, D.C.3    Londei, M.4
  • 41
    • 0036569357 scopus 로고    scopus 로고
    • Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation
    • Sombroek CC, Stam AG, Masterson AJ, et al.: Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 2002, 168:4333-4343.
    • (2002) J. Immunol. , vol.168 , pp. 4333-4343
    • Sombroek, C.C.1    Stam, A.G.2    Masterson, A.J.3
  • 42
    • 0034653462 scopus 로고    scopus 로고
    • Tumor-induced apoptosis of T lymphocytes: Elucidation of intracellular apoptotic events
    • Gastman BR, Johnson DE, Whiteside TL, Rabinowich H: Tumor-induced apoptosis of T lymphocytes: elucidation of intracellular apoptotic events. Blood 2000, 95:2015-2023.
    • (2000) Blood , vol.95 , pp. 2015-2023
    • Gastman, B.R.1    Johnson, D.E.2    Whiteside, T.L.3    Rabinowich, H.4
  • 43
    • 0030659077 scopus 로고    scopus 로고
    • Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma
    • Marrogi AJ, Munshi A, Merogi AJ, et al.: Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer 1997, 74:492-501.
    • (1997) Int. J. Cancer , vol.74 , pp. 492-501
    • Marrogi, A.J.1    Munshi, A.2    Merogi, A.J.3
  • 44
    • 0033060409 scopus 로고    scopus 로고
    • Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: A study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome
    • Lespagnard L, Gancberg D, Rouas G, et al.: Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 1999, 84:309-314.
    • (1999) Int. J. Cancer , vol.84 , pp. 309-314
    • Lespagnard, L.1    Gancberg, D.2    Rouas, G.3
  • 45
    • 0028013266 scopus 로고
    • Local recurrences following mastectomy: Support for the concept of tumor dormancy
    • Demicheli R, Terenziani M, Valagussa P, et al.: Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 1994, 86:45-48.
    • (1994) J. Natl. Cancer Inst. , vol.86 , pp. 45-48
    • Demicheli, R.1    Terenziani, M.2    Valagussa, P.3
  • 46
    • 0028951043 scopus 로고
    • Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    • Holmgren L, O'Reilly MS, Folkman J: Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995, 1:149-153.
    • (1995) Nat. Med. , vol.1 , pp. 149-153
    • Holmgren, L.1    O'Reilly, M.S.2    Folkman, J.3
  • 47
    • 0027970092 scopus 로고
    • Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
    • O'Reilly MS, Holmgren L, Shing Y, et al.: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328.
    • (1994) Cell , vol.79 , pp. 315-328
    • O'Reilly, M.S.1    Holmgren, L.2    Shing, Y.3
  • 48
    • 0031454617 scopus 로고    scopus 로고
    • Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
    • O'Reilly MS, Boehm T, Shing Y, et al.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
    • (1997) Cell , vol.88 , pp. 277-285
    • O'Reilly, M.S.1    Boehm, T.2    Shing, Y.3
  • 49
    • 0030576517 scopus 로고    scopus 로고
    • Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    • Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
    • (1996) Cell , vol.86 , pp. 353-364
    • Hanahan, D.1    Folkman, J.2
  • 50
    • 0032544686 scopus 로고    scopus 로고
    • Tumor induction of VEGF promoter activity in stromal cells
    • Fukumura D, Xavier R, Sugiura T, et al.: Tumor induction of VEGF promoter activity in stromal cells. Cell 1998, 94:715-725.
    • (1998) Cell , vol.94 , pp. 715-725
    • Fukumura, D.1    Xavier, R.2    Sugiura, T.3
  • 51
  • 52
    • 0021684729 scopus 로고
    • Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages
    • Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 1984, 51:635-642.
    • (1984) Lab. Invest. , vol.51 , pp. 635-642
    • Polverini, P.J.1    Leibovich, S.J.2
  • 53
    • 0025147371 scopus 로고
    • A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
    • Good DJ, Polverini PJ, Rastinejad F, et al.: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A 1990, 87:6624-6628.
    • (1990) Proc. Natl. Acad. Sci. U. S. A. , vol.87 , pp. 6624-6628
    • Good, D.J.1    Polverini, P.J.2    Rastinejad, F.3
  • 54
    • 0022252997 scopus 로고
    • Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth
    • Homandberg GA, Williams JE, Grant D, et al.: Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. Am J Pathol 1985, 120:327-332.
    • (1985) Am. J. Pathol. , vol.120 , pp. 327-332
    • Homandberg, G.A.1    Williams, J.E.2    Grant, D.3
  • 55
    • 0032582635 scopus 로고    scopus 로고
    • Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells
    • Lee TH, Rhim T, Kim SS: Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells. J Biol Chem 1998, 273:28805-28812.
    • (1998) J. Biol. Chem. , vol.273 , pp. 28805-28812
    • Lee, T.H.1    Rhim, T.2    Kim, S.S.3
  • 56
    • 0031454617 scopus 로고    scopus 로고
    • Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
    • O'Reilly MS, Boehm T, Shing Y, et al.: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
    • (1997) Cell , vol.88 , pp. 277-285
    • O'Reilly, M.S.1    Boehm, T.2    Shing, Y.3
  • 57
    • 15644374164 scopus 로고    scopus 로고
    • Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers
    • Morelli D, Lazzerini D, Cazzaniga S, et al.: Evaluation of the balance between angiogenic and antiangiogenic circulating factors in patients with breast and gastrointestinal cancers. Clin Cancer Res 1998, 4:1221-1225.
    • (1998) Clin. Cancer Res. , vol.4 , pp. 1221-1225
    • Morelli, D.1    Lazzerini, D.2    Cazzaniga, S.3
  • 58
    • 0031426425 scopus 로고    scopus 로고
    • Platelet: Transporter of vascular endothelial growth factor
    • Verheul HM, Hoekman K, Luykx-de Bakker S, et al.: Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 1997, 3:2187-2190.
    • (1997) Clin. Cancer Res. , vol.3 , pp. 2187-2190
    • Verheul, H.M.1    Hoekman, K.2    Luykx-de Bakker, S.3
  • 59
    • 0033968571 scopus 로고    scopus 로고
    • Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas
    • Verheul HM, Hoekman K, Lupu F, et al.: Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas. Clin Cancer Res 2000, 6:166-71.
    • (2000) Clin. Cancer Res. , vol.6 , pp. 166-171
    • Verheul, H.M.1    Hoekman, K.2    Lupu, F.3
  • 60
    • 0034672373 scopus 로고    scopus 로고
    • Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets
    • Verheul HM, Jorna AS, Hoekman K, et al.: Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood 2000, 96:4216-4221.
    • (2000) Blood , vol.96 , pp. 4216-4221
    • Verheul, H.M.1    Jorna, A.S.2    Hoekman, K.3
  • 61
    • 0032483682 scopus 로고    scopus 로고
    • Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents
    • Joseph IB, Isaacs JT: Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J Natl Cancer Inst 1998, 90:1648-1653.
    • (1998) J. Natl. Cancer Inst. , vol.90 , pp. 1648-1653
    • Joseph, I.B.1    Isaacs, J.T.2
  • 62
    • 0030998660 scopus 로고    scopus 로고
    • Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
    • Dong Z, Kumar R, Yang X, Fidler IJ: Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 1997, 88:801-810.
    • (1997) Cell , vol.88 , pp. 801-810
    • Dong, Z.1    Kumar, R.2    Yang, X.3    Fidler, I.J.4
  • 63
    • 0032541472 scopus 로고    scopus 로고
    • Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor
    • Dong Z, Yoneda J, Kumar R, Fidler IJ: Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor. J Exp Med 1998, 188:755-763.
    • (1998) J. Exp. Med. , vol.188 , pp. 755-763
    • Dong, Z.1    Yoneda, J.2    Kumar, R.3    Fidler, I.J.4
  • 64
    • 0031036948 scopus 로고    scopus 로고
    • Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer
    • Honkoop AH, Pinedo HM, de Jong JS, et al.: Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 1997, 107:211-218.
    • (1997) Am. J. Clin. Pathol. , vol.107 , pp. 211-218
    • Honkoop, A.H.1    Pinedo, H.M.2    de Jong, J.S.3
  • 65
    • 0032485487 scopus 로고    scopus 로고
    • Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
    • Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998, 392:86-89.
    • (1998) Nature , vol.392 , pp. 86-89
    • Albert, M.L.1    Sauter, B.2    Bhardwaj, N.3
  • 66
    • 0031798137 scopus 로고    scopus 로고
    • Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells
    • Inaba K, Turley S, Yamaide F, et al.: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 1998, 188:2163-2173.
    • (1998) J. Exp. Med. , vol.188 , pp. 2163-2173
    • Inaba, K.1    Turley, S.2    Yamaide, F.3
  • 67
    • 0034614886 scopus 로고    scopus 로고
    • The induction of tolerance by dendritic cells that have captured apoptotic cells
    • Steinman RM, Turley S, Mellman I, Inaba K: The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000, 191:411-416.
    • (2000) J. Exp. Med. , vol.191 , pp. 411-416
    • Steinman, R.M.1    Turley, S.2    Mellman, I.3    Inaba, K.4
  • 68
    • 0032695108 scopus 로고    scopus 로고
    • Natural adjuvants: Endogenous activators of dendritic cells
    • Gallucci S, Lolkema M, Matzinger P: Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999, 5:1249-1255.
    • (1999) Nat. Med. , vol.5 , pp. 1249-1255
    • Gallucci, S.1    Lolkema, M.2    Matzinger, P.3
  • 69
    • 0034614897 scopus 로고    scopus 로고
    • Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
    • Sauter B, Albert ML, Francisco L, et al.: Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med 2000, 191:423-434.
    • (2000) J. Exp. Med. , vol.191 , pp. 423-434
    • Sauter, B.1    Albert, M.L.2    Francisco, L.3
  • 70
    • 0035328683 scopus 로고    scopus 로고
    • Cyclophosphamide doxorubicin and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
    • Machiels JP, Reilly RT, Emens LA, et al.: Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 2001, 61:3689-3697.
    • (2001) Cancer Res. , vol.61 , pp. 3689-3697
    • Machiels, J.P.1    Reilly, R.T.2    Emens, L.A.3
  • 71
    • 0023203184 scopus 로고
    • A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma
    • Carmo-Pereira J, Costa FO, Henriques E, et al.: A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma. Br J Cancer 1987, 56:471-473
    • (1987) Br. J. Cancer , vol.56 , pp. 471-473
    • Carmo-Pereira, J.1    Costa, F.O.2    Henriques, E.3
  • 72
    • 0023798680 scopus 로고
    • Preclinical studies and clinical correlation of the effect of alkylating dose
    • Frei E III, Teicher BA, Holden SA, et al.: Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res 1988, 48:6417-6423.
    • (1988) Cancer Res. , vol.48 , pp. 6417-6423
    • Frei III, E.1    Teicher, B.A.2    Holden, S.A.3
  • 73
    • 0030032778 scopus 로고    scopus 로고
    • Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients
    • Honkoop AH, Hoekman K, Wagstaff J, et al.: Dose-intensive chemotherapy with doxorubicin, cyclophosphamide and GM-CSF fails to improve survival of metastatic breast cancer patients. Ann Oncol 1996, 7:35-39.
    • (1996) Ann. Oncol. , vol.7 , pp. 35-39
    • Honkoop, A.H.1    Hoekman, K.2    Wagstaff, J.3
  • 74
    • 0021744793 scopus 로고
    • The importance of dose intensity in chemotherapy of metastatic breast cancer
    • Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984, 2:1281-1288.
    • (1984) J. Clin. Oncol. , vol.2 , pp. 1281-1288
    • Hryniuk, W.1    Bush, H.2
  • 75
    • 0023127989 scopus 로고
    • A phase I-II study of intensive-dose adriamycin for advanced breast cancer
    • Jones RB, Holland JF, Bhardwaj S, et al.: A phase I-II study of intensive-dose adriamycin for advanced breast cancer. J Clin Oncol 1987, 5:172-177.
    • (1987) J. Clin. Oncol. , vol.5 , pp. 172-177
    • Jones, R.B.1    Holland, J.F.2    Bhardwaj, S.3
  • 76
    • 0026000905 scopus 로고
    • Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer
    • Hoekman K, Wagstaff J, van Groeningen CJ, et al.: Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer. J Natl Cancer Inst 1991, 83:1546-1553.
    • (1991) J. Natl. Cancer Inst. , vol.83 , pp. 1546-1553
    • Hoekman, K.1    Wagstaff, J.2    van Groeningen, C.J.3
  • 77
    • 0033061169 scopus 로고    scopus 로고
    • Prolonged neoadjuvant treatment in locally advanced tumours: A novel concept based on biological considerations
    • Luykx-de Bakker SA, Verheul HM, de Gruijl TD, Pinedo HM: Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerations. Ann Oncol 1999, 10:155-160.
    • (1999) Ann. Oncol. , vol.10 , pp. 155-160
    • Luykx-de Bakker, S.A.1    Verheul, H.M.2    de Gruijl, T.D.3    Pinedo, H.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.